{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:06:50Z","timestamp":1761512810177},"reference-count":10,"publisher":"Informa Healthcare","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1517\/13543784.2010.489547","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T05:21:45Z","timestamp":1273296105000},"page":"909-911","source":"Crossref","is-referenced-by-count":4,"title":["Raxibacumab for inhalational anthrax: an effective specific therapeutic approach?"],"prefix":"10.1517","volume":"19","author":[{"given":"Sabina A","family":"Antoniu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2010,5,7]]},"reference":[{"issue":"7","key":"CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010714","volume":"8","author":"Banks DJ","year":"2006","journal-title":"Expert Rev Mol Med"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1038\/n35101999"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1086\/512372"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.22.2104"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2217\/17460913.4.1.35"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602748103"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.01.094"},{"issue":"1","key":"CIT0008","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/523578","volume":"46","author":"Grabenstein JD","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"CIT0009","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","volume":"51","author":"Welkos S","year":"2002","journal-title":"J Med Microbiol"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810603"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.2010.489547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T07:58:32Z","timestamp":1497859112000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.2010.489547"}},"subtitle":["Evaluation of: Migone TS, Subramanian GM, Zhong J, et al. Raxibacumab for the treatment of inhalational anthrax. N Engl J Med 2009;361(2):135-44"],"short-title":[],"issued":{"date-parts":[[2010,5,7]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,5,15]]},"published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1517\/13543784.2010.489547"],"URL":"https:\/\/doi.org\/10.1517\/13543784.2010.489547","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,7]]}}}